Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 58

Related Articles by Review for PubMed (Select 17565352)

1.

Persistent expression of hF.IX After tolerance induction by in utero or neonatal administration of AAV-1-F.IX in hemophilia B mice.

Sabatino DE, Mackenzie TC, Peranteau W, Edmonson S, Campagnoli C, Liu YL, Flake AW, High KA.

Mol Ther. 2007 Sep;15(9):1677-85. Epub 2007 Jun 12.

PMID:
17565352
2.

Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia.

High KA.

Trans Am Clin Climatol Assoc. 2003;114:337-51; discussion 351-2. Review.

3.

AAV-mediated gene transfer for hemophilia.

High KA.

Ann N Y Acad Sci. 2001 Dec;953:64-74. Review.

PMID:
11795424
4.

Technology evaluation: AAV factor IX gene therapy, Avigen Inc.

Fabb SA, Dickson JG.

Curr Opin Mol Ther. 2000 Oct;2(5):601-6. Review.

PMID:
11249763
5.

AAV-mediated gene transfer for the treatment of hemophilia B: problems and prospects.

Hasbrouck NC, High KA.

Gene Ther. 2008 Jun;15(11):870-5. doi: 10.1038/gt.2008.71. Epub 2008 Apr 24. Review.

PMID:
18432276
6.

Immune responses to AAV in clinical trials.

Mingozzi F, High KA.

Curr Gene Ther. 2007 Oct;7(5):316-24. Review.

PMID:
17979678
7.

Adeno-associated virus-mediated gene transfer for hemophilia B.

High KA.

Int J Hematol. 2002 Nov;76(4):310-8. Review.

PMID:
12463593
8.

Gene therapy for hemophilia B: AAV-mediated transfer of the gene for coagulation factor IX to human muscle.

Larson PJ, High KA.

Adv Exp Med Biol. 2001;489:45-57. Review. No abstract available.

PMID:
11554590
9.

Preclinical gene therapy studies for hemophilia using adeno-associated virus (AAV) vectors.

Couto LB.

Semin Thromb Hemost. 2004 Apr;30(2):161-71. Review.

PMID:
15118928
10.

Gene therapy for the hemophilias.

VandenDriessche T, Collen D, Chuah MK.

J Thromb Haemost. 2003 Jul;1(7):1550-8. Review.

PMID:
12871290
11.

AAV vectors for hemophilia B gene therapy.

Chao H, Walsh CE.

Mt Sinai J Med. 2004 Oct;71(5):305-13. Review.

PMID:
15543431
12.

Gene therapy for hemophilia.

Ponder KP.

Curr Opin Hematol. 2006 Sep;13(5):301-7. Review.

PMID:
16888433
13.

Parvovirus-mediated gene transfer for the haemophilias.

Walsh CE, Chao H.

Haemophilia. 2002 Mar;8 Suppl 2:60-7. Review.

PMID:
11966856
14.

AAV-mediated gene therapy for hemophilia.

Couto LB, Pierce GF.

Curr Opin Mol Ther. 2003 Oct;5(5):517-23. Review.

PMID:
14601521
15.

Adeno-associated virus-mediated gene transfer of factor IX for treatment of hemophilia B by gene therapy.

Herzog RW, High KA.

Thromb Haemost. 1999 Aug;82(2):540-6. Review. No abstract available.

PMID:
10605748
16.

Immune responses to adeno-associated virus vectors.

Zaiss AK, Muruve DA.

Curr Gene Ther. 2005 Jun;5(3):323-31. Review.

PMID:
15975009
17.

AAV as an immunogen.

Vandenberghe LH, Wilson JM.

Curr Gene Ther. 2007 Oct;7(5):325-33. Review.

PMID:
17979679
18.

Immune implications of gene therapy for hemophilia.

Herzog RW, Dobrzynski E.

Semin Thromb Hemost. 2004 Apr;30(2):215-26. Review.

PMID:
15118933
19.

Viral vector-mediated gene therapy for hemophilia.

VandenDriessche T, Collen D, Chuah MK.

Curr Gene Ther. 2001 Sep;1(3):301-15. Review.

PMID:
12109144
20.

Gene therapy for hemophilia "A" and "B": efficacy, safety and immune consequences.

Chuah M, Vandendriessche T.

Verh K Acad Geneeskd Belg. 2007;69(5-6):315-34. Review.

PMID:
18351211
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk